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Complementary medicine (CM), which includes a range of self-directed and practitioner-directed 
health practices (e.g., meditation and yoga, chiropractic, naturopathy) and products (e.g., herbal 
medicine, homeopathy, nutritional supplements), now constitutes a sizeable part of the Australian 
healthcare sector1. Despite the increasingly significant role of CM in Australian healthcare, it remains 
unclear how regulatory and consumer protections interface with this care. This lack of clarity is 
further compounded by the increasing integration of biomedical and complementary health 
approaches under the moniker of integrative medicine2.  
Integrative medicine’s combination of CM and conventional medicine approaches brings with it not 
only a blend of clinical and philosophical healthcare approaches, but also a blend of professional 
norms and standards, duties and precedents that complicate regulatory and legislative examination of 
this form of practice. Recently, the risks associated with CM products, and cases where 
unprofessional and negligent treatment by CM practitioners has resulted in deaths, personal injury and 
unethical practices, have been publicly profiled3, highlighting the failure of contemporary regulatory 
and legislative consumer protection measures to keep pace with the rise in CM use.  
Lack of coherent regulatory or legislative mechanisms has forced consumer protection to be enacted 
through novel and often untested mechanisms. For example, failure of therapeutics goods or 
practitioner legislation to deal with misleading claims surrounding homeopathic vaccination required 
action via Australian Consumer Law, which is not often well-placed to deal with the nuances and 
priorities of health-specific legislation4. Governments have been hesitant to extend registration to any 
new health professions (including – but not limited to – CM professions)5, and instead use ‘catch-all’ 
legislation to target unregistered practitioners. However, this approach has brought with it the risk of 
regulatory chill in ensuring consumer protection in other areas that may not be adequately covered by 
current legislation6.  
The regulatory environment is further complicated by the overlapping or shared jurisdiction of 
multiple regulators for certain CM products and practices: for example, advertising claims made by 
CM manufacturers may fall under the jurisdiction of differing statutory or self-regulatory authorities 
depending on whether a false claim has been made in-store, on printed advertising material, on 
television or online7. Furthermore, an ad-hoc approach to CM regulation has resulted in several 
inconsistencies and inefficiencies in consumer protection mechanisms. Although variable and sub-
standard training of CM practitioners has been identified as an important consumer protection issue, 
government policies may have in part encouraged an active reduction in standards by subsidising 
training courses that do not even meet government requirements for recognition8. 
Despite the lack of development in this area, the interface between CM and regulatory and legislative 
spheres is increasingly significant. Not only do CM issues represent a significant proportion of 
disciplinary actions against conventional health practitioners, but lack of regulatory attention around 
CM may allow practitioners previously prohibited as conventional providers to re-brand as CM 
providers9. There may also be significant economic consequences   due to the lack of appropriate 
regulatory and legislative infrastructure around CM issues – the longest disciplinary case in Australian 
history (Chiropractic Board of Australia v. Hooper) involved unorthodox CM treatments, the 
complexities of which attributed in some part to the case’s length, and many of the mistakes leading 
to the mishandling of the Pan Pharmaceuticals recall (historically remembered as a CM event, but 
actually initiated due to issues with conventional pharmaceutical manufacturing) were largely the 
result of details of regulatory provisions simply being non-existent for CM compared to conventional 
products10. 
CM is generally defined as those practices not traditionally associated with biomedical practice or the 
conventional medical curriculum11. This definition – one of exclusion and convenience rather than 
one of systematic and coherent codification – means that CM often sits outside the regulatory and 
legal structures that exist for other, more conventional, health practices. CM use is a ubiquitous aspect 
of an increasingly consumer-driven model of healthcare delivery, and plays an increasingly prominent 
role in the Australian health sector. Yet a review of the literature reveals there is limited doctrinal and 
empirical research investigating the quality and integrity of protections for consumers in light of the 
high levels of use of CM and its significant role in healthcare in Australia.  
This absence of critical and rigorous examination often means that questions around CM issues are 
increasingly interfacing with regulatory and legislative structure ill-equipped to deal with CM 
matters9. Despite the large number of Australian consumers choosing CM products and services, CM 
remains a practice that is marginalised within much of the Australian healthcare community, with the 
regulatory and legislative consumer protection mechanisms for CM, and the relationship between 
CAM consumers, practitioners, manufacturers and regulators and the regulatory and legislative 
environment, virtually undocumented. The controversial (and marginalised) nature of CM can also 
bring with it ideological opposition to “recognising” CM practices through traditional regulatory 
mechanisms and safeguards, with debate around the topic of legislative and regulatory requirements 
of CM often remaining polemic, polarised and opinion-based12. Given the increasing role of 
integrative medicine, however, there is an urgent need for further empirical research into whether 
current regulatory arrangements provide appropriate consumer protection, to determine the consumer 
protection measures that are needed, and to investigate the role the CM industry perceives that 
regulation plays in the management of legal risk.  
Although the Australian health regulatory framework is generally well developed, the integration of 
CM within that framework remains problematic. Very little is currently known about the legal and 
regulatory risks associated with what CM practitioners and manufacturers do in their practice and the 
impact on consumers, making it difficult to develop regulatory and legislative provisions that are both 
effective and workable. As such, there is an urgent need for a greater understanding of the current 
interface between CM and Australian society at all levels, including gaps which exist in the regulatory 
and legislative domains. Evidence-based, efficient and effective legislative and regulatory reform 
requires that new developments be focused on CM consumer needs, addressing identified legal risk 
issues and designed to provide improvements in health consumer protection, necessitating the 
significance and importance of further work in this area.  
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